Compare Alexandria Real Estate Equities Inc (ARE) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alexandria Real Estate Equities Inc vs 10X Genomics Inc — how do they compare? Alexandria Real Estate Equities Inc trades at $48.5 (market cap $8.28B), while 10X Genomics Inc trades at $59 (market cap $7.61B). The key difference: Alexandria Real Estate Equities Inc and 10X Genomics Inc are close in size by market cap, and Alexandria Real Estate Equities Inc pays a 5.99% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| ARE | TXG | |
|---|---|---|
Market Cap | $8.28B | $7.61B |
Sector | Real Estate | Health |
52-Week High | $87.45 | $58.57 |
52-Week Low | $40.41 | $11.34 |
Enterprise Value | $20.98B | $7.14B |
Dividend Yield | 5.99% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Alexandria Real Estate Equities Inc
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.
Read more on ARE →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
